PASSAGE BIO
Live / Registered — Registered (as of 22 Aug 2023)
What this means for you
Registered since 22 Aug 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88764198
- Registration number
- 7145870
- Mark type
- Stylized text
- Filed
- 17 Jan 2020
- Published for opposition
- 19 May 2020
- Registered
- 22 Aug 2023
- Attorney of record
- Connie L. Ellerbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in gene therapy, genetic medicines and regenerative therapies; pharmaceuticals and medical preparations and substances for genetically based diseases and rare disorders; pharmaceuticals and medical preparations and substances for use in the prevention and treatment of diseases and disorders of the central nervous system; medicines for human purposes, namely, for treating genetically based diseases and disorders; pharmaceutical compositions, namely, viral vectors for use in the delivery of gene therapy; pharmaceutical compositions, namely, viral vectors for use in the delivery of gene therapy for rare monogenic central nervous system diseases; pharmaceutical compositions containing adeno-associated virus (AAV) vectors for a system delivering genes to biological cells for use in the treatment of diseases, sicknesses, and disorders
- Class 042 — Scientific and technological services: Pharmaceutical research and development; clinical research in the field of genetic medicine, gene therapy and regenerative medicines; testing, inspection, research, or development of pharmaceutical preparations and substances for genetic medicine, gene therapy and regenerative medicines; biological information analysis, namely, genetic testing for medical research purposes; scientific research in the fields of medicine, genetics, genetic medicines, regenerative medicines, gene therapy, biologics, and central nervous system diseases; providing medical and scientific research information in the fields of pharmaceuticals, genetics and clinical trials; medical and scientific research, namely, conducting clinical trials for others; compiling scientific and clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of medicine, genetics, genetics medicines, regenerative medicines, gene therapy, biologics, and rare disease
Owner
- Passage Bio, Inc., Philadelphia, PA, US
- Passage Bio, Inc., Philadelphia, PA, US
- Passage Bio, Inc., Philadelphia, PA, US
Prosecution history
- 22 Aug 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Aug 2023 — REGISTERED-PRINCIPAL REGISTER
- 18 Jul 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Jul 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Jul 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Jul 2023 — USE AMENDMENT FILED
- 14 Jul 2023 — TEAS STATEMENT OF USE RECEIVED
- 28 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jan 2023 — SOU EXTENSION 5 GRANTED
- 12 Jan 2023 — SOU EXTENSION 5 FILED
- 26 Jan 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Jan 2023 — SOU TEAS EXTENSION RECEIVED
- 08 Jul 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jul 2022 — SOU EXTENSION 4 GRANTED
- 06 Jul 2022 — SOU EXTENSION 4 FILED